Hims & Hers Health Pre-Tax Profit Margin 2020-2025 | HIMS
Current and historical pre-tax profit margin for Hims & Hers Health (HIMS) from 2020 to 2025. Pre-tax profit margin can be defined as earnings before taxes as a portion of total revenue. Hims & Hers Health pre-tax profit margin for the three months ending September 30, 2025 was .
| Hims & Hers Health Pre-Tax Profit Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM Pre-Tax Income | Pre-Tax Margin |
| 2025-09-30 | $2.21B | $0.13B | 5.74% |
| 2025-06-30 | $2.01B | $0.14B | 6.90% |
| 2025-03-31 | $1.79B | $0.12B | 6.67% |
| 2024-12-31 | $1.48B | $0.07B | 4.81% |
| 2024-09-30 | $1.24B | $0.05B | 4.10% |
| 2024-06-30 | $1.07B | $0.02B | 1.87% |
| 2024-03-31 | $0.96B | 0 | 0.00% |
| 2023-12-31 | $0.87B | $-0.02B | -2.52% |
| 2023-09-30 | $0.79B | $-0.04B | -4.41% |
| 2023-06-30 | $0.71B | $-0.05B | -6.61% |
| 2023-03-31 | $0.62B | $-0.06B | -9.72% |
| 2022-12-31 | $0.53B | $-0.07B | -12.52% |
| 2022-09-30 | $0.45B | $-0.09B | -19.33% |
| 2022-06-30 | $0.37B | $-0.09B | -22.99% |
| 2022-03-31 | $0.32B | $-0.08B | -23.36% |
| 2021-12-31 | $0.27B | $-0.11B | -40.44% |
| 2021-09-30 | $0.23B | $-0.08B | -36.84% |
| 2021-06-30 | $0.20B | $-0.07B | -36.41% |
| 2021-03-31 | $0.17B | $-0.06B | -37.06% |
| 2020-12-31 | $0.15B | $-0.02B | -12.16% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $5.240B | $1.477B |
| Hims & Hers Health Inc. is a multi-specialty telehealth platform that connects consumers to licensed healthcare professionals, enabling medical care for numerous conditions related to mental health, sexual health, dermatology, primary care and more. Hims & Hers Health Inc., formerly known as Oaktree Acquisition Corp., is based in San Francisco. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $30.189B | 34.91 |
| Tempus AI (TEM) | United States | $9.769B | 0.00 |
| Doximity (DOCS) | United States | $5.221B | 22.18 |
| IRhythm Holdings (IRTC) | United States | $4.719B | 0.00 |
| Privia Health (PRVA) | United States | $2.705B | 169.15 |
| Hinge Health (HNGE) | United States | $2.454B | 0.00 |
| Heartflow (HTFL) | United States | $2.362B | 0.00 |
| 10x Genomics (TXG) | United States | $2.355B | 0.00 |
| Inspire Medical Systems (INSP) | United States | $1.909B | 31.59 |
| Omnicell (OMCL) | United States | $1.664B | 46.34 |
| Azenta (AZTA) | United States | $1.323B | 53.19 |
| Enovis (ENOV) | United States | $1.292B | 6.78 |
| Clover Health Investments (CLOV) | United States | $1.101B | 0.00 |
| Schrodinger (SDGR) | United States | $0.994B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.854B | 0.00 |
| Phreesia (PHR) | United States | $0.736B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.725B | 0.00 |
| Talkspace (TALK) | United States | $0.643B | 129.33 |
| Standard BioTools (LAB) | United States | $0.485B | 0.00 |
| Claritev (CTEV) | United States | $0.428B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.324B | 0.00 |
| Evolent Health (EVH) | United States | $0.318B | 0.00 |
| Carlsmed (CARL) | United States | $0.310B | 0.00 |
| TruBridge (TBRG) | United States | $0.304B | 13.97 |
| Senseonics Holdings (SENS) | United States | $0.304B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.256B | 0.00 |
| CapsoVision (CV) | United States | $0.232B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.228B | 0.00 |
| Insight Molecular Diagnostics (IMDX) | United States | $0.210B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.167B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.158B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.152B | 0.00 |
| CareCloud (CCLD) | United States | $0.104B | 5.70 |
| Outset Medical (OM) | United States | $0.082B | 0.00 |
| American Well (AMWL) | United States | $0.073B | 0.00 |
| NetraMark Holdings (AINMF) | Canada | $0.065B | 0.00 |
| 111 (YI) | China | $0.064B | 0.00 |
| Pulmonx (LUNG) | United States | $0.062B | 0.00 |
| HeartBeam (BEAT) | United States | $0.049B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.042B | 0.00 |
| Precipio (PRPO) | United States | $0.035B | 0.00 |
| Evaxion - (EVAX) | Denmark | $0.028B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.020B | 0.00 |
| Lunai Bioworks (LNAI) | United States | $0.016B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.015B | 0.00 |
| Movano (MOVE) | United States | $0.013B | 0.00 |
| HeartSciences (HSCS) | United States | $0.010B | 0.00 |
| ITonic Holdings (ITOC) | China | $0.007B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.007B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.006B | 0.00 |
| Zhongchao (ZCMD) | China | $0.006B | 0.00 |
| PROFUSA (PFSA) | United States | $0.005B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.002B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.001B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.001B | 0.00 |